Featured News

The Celiac Disease Foundation was proud to be an endorsement partner of the 2019 James W. Freston Conference – Food at the Intersection of Gut Health and Disease to educate…

On August 13th, 2019, Innovate Biopharmaceuticals, Inc. (Innovate) announced the first patient has been dosed in its Phase 3 clinical trial for patients with celiac disease. The CeD LA 3001…

Proud Sponsor Enjoy Life has partnered with the Celiac Disease Foundation to make a positive impact this Back-to-School season.

Researchers are collecting blood samples to learn more about the antigens that cause certain T cells to trigger intestinal damage in celiac disease patients. Complete a 30-minute study from home & be compensated $50 for your time.

I’m writing to invite you to join me and others from across the healthcare community at the 2019 Patient-Centered Outcomes Research Institute (PCORI) Annual Meeting, being held September 18-20 at…

Written by Francisco Leon, MD, PhD, Chief Scientific Officer, Co-Founder, Provention Bio Current guidelines recommend routine follow-up for celiac disease with dietary interviews and celiac blood tests, though these methods…

All over the country, parents are getting ready to send their children back to school. Our children, Alexander Solomon, Amanda Solomon, and Draya Ramer, have celiac disease. Returning to school presents special challenges…

Celiac Disease Foundation Partners with Mediaplanet for Digestive Health & Wellness Campaign

On April 9, 2019, Marilyn G. Geller, CEO of the Celiac Disease Foundation, testified before the House Appropriations Subcommittee overseeing the funding for the Department of Health and Human Services, including the National Institutes of Health (NIH).

We have great news to share from Washington, D.C. Today, the U.S. House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies released report language under the National Institute of Allergy and Infectious Diseases.